Ascendis Pharma AS (ASND): Kapitalflussrechnung
Kennzahl in 1000 EUR | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 691.710,419 | 363.641 | 266.718 | 51.174 | 7.778 | 6.953 | 13.375 | 10.581 | 1.530 | 4.606 | 8.118 | 13.983 | 20.408 | 15.583 |
Cashflow aus operativer Geschäftstätigkeit | 51.769,836 | -306.197 | -467.361 | -495.699 | -417.649 | -271.548 | -175.936 | -138.802 | -95.099 | -60.179 | -43.466 | -18.403 | 6.310 | -652 |
▸ Operative Cashflow Marge | 7,48% | -84,2% | -175,23% | -968,65% | -5.369,62% | -3.905,48% | -1.315,41% | -1.311,8% | -6.215,62% | -1.306,53% | -535,43% | -131,61% | 30,92% | -4,18% |
Investitionsausgaben (CapEx) | 8.150,119 | 1.427 | 2.442 | 14.489 | 24.234 | 21.552 | 5.159 | 2.648 | 941 | 672 | 1.039 | 405 | 1.195 | 291 |
Cashflow aus Investitionstätigkeit | -8.150,12 | 6.876 | 286.474 | 61.732 | -110.579 | -291.199 | -5.159 | -2.648 | -941 | -672 | -1.039 | -405 | -1.195 | -291 |
Cashflow aus Finanzierungstätigkeit | 34.894,236 | 443.929 | 134.292 | 396.773 | 351.387 | 602.650 | 493.593 | 203.267 | 124.721 | 117.462 | 105.742 | 47.907 | -220 | -205 |
Freier Cashflow | 43.619,717 | -307.624 | -469.803 | -510.188 | -441.883 | -293.100 | -181.095 | -141.450 | -96.040 | -60.851 | -44.505 | -18.808 | 5.115 | -943 |
▸ Freie Cashflow Marge | 6,31% | -84,6% | -176,14% | -996,97% | -5.681,19% | -4.215,45% | -1.353,98% | -1.336,83% | -6.277,12% | -1.321,12% | -548,23% | -134,51% | 25,06% | -6,05% |
Ausgeschüttete Dividenden | - | - | - | -5.060,193 | -33.142 | - | - | - | - | - | - | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | -16.709,428 | - | -1.812 | -105.305 | -21.605 | - | 529.332 | 216.385 | 133.109 | 125.966 | 114.138 | 138.081,297 | 114.138 | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.